Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Selection of the R263K mutation to dolutegravir in cerebrospinal fluid HIV-1 virus in one patient with HIV-associated neurocognitive disorders.

AIDS (London, England) - 10 Sept 2016

Vassallo Matteo, De Monte Anne, Durant Jacques, Dunais Brigitte, Cottalorda Jacqueline

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Cerebellar Diseases
Share to Heterocyclic Compounds, 3-Ring

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Integrase

Share to HIV Integrase Inhibitors

Share to Neurocognitive Disorders

Share to Oxazines

Share to Pyridones

Source

Identifiers

PMID: 27574797
DOI: 10.1097/QAD.0000000000001194

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Selection of the R263K mutation to dolutegravir in cerebrospinal fluid HIV-1 virus in one patient with HIV-associated neurocognitive disorders.PMID 27574797Read ↗

Selection of an M184V mutation in the cerebrospinal fluid of a treatment-naive HIV-infected individual starting darunavir-based therapy.Semantic proximity Read ↗

Genetic and biological analysis of variants derived from the cerebrospinal fluid of HIV type 1 subtype B- and D- infected patients with and without AIDS dementia complex.Semantic proximity Read ↗

Selection of L74V mutation in reverse transcriptase of HIV-1 subtype D by a tenofovir DF-lamivudine based regimen.Semantic proximity Read ↗

The absence of HIV mutations in cerebrospinal fluid and in peripheral blood mononuclear cells during a regimen containing Trizivir plus tenofovir.Semantic proximity Read ↗

An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy.Semantic proximity Read ↗

Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive statusSemantic proximity Read ↗

Selection of K65R mutation in HIV-2-infected patients receiving tenofovir-containing regimen.Semantic proximity Read ↗

The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia.Semantic proximity Read ↗

Response to antiretroviral therapy in a patient with an uncommon codon 69 insertion in the human immunodeficiency virus type 1 reverse transcriptase.Semantic proximity Read ↗

Deep Sequencing of HIV-1 in Cerebrospinal Fluid.Semantic proximity Read ↗

High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis.Semantic proximity Read ↗

Risk factors for selection of the L74I reverse transcriptase mutation in human immunodeficiency virus type 1-infected patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.